Literature DB >> 6092671

The major site of tyrosine phosphorylation in polyomavirus middle T antigen is not required for transformation.

A M Mes-Masson, B Schaffhausen, J A Hassell.   

Abstract

The induction of tumors and cellular transformation mediated by polyomavirus requires the action of middle T antigen. Accordingly, we have begun to define the domains of the viral protein important for these processes to learn more about its site and mechanism of action. One of the domains of middle T antigen which is thought to be important for its function includes a stretch of acidic amino acids and a vicinal tyrosine residue (tyrosine 315), the major site of tyrosine phosphorylation in vitro. To determine whether these acidic amino acids and tyrosine 315 are required to maintain the transforming activity of middle T antigen, we constructed deletions within the DNA sequences encoding these amino acids and measured the capacity of the resulting mutants to transform Rat-1 cells in culture. This was accomplished by using in vitro mutagenesis techniques with molecularly cloned polyomavirus DNA. Seven mutants were isolated. Five of these proved incapable of transforming Rat-1 cells and were found to contain deletions which altered the reading frame for middle T antigen. However, two mutants, pPdl1-4 and pPdl2-7, retained the capacity to transform Rat-1 cells at high frequencies. The middle T antigen encoded by one of these mutants, pPdl1-4, lacks part of the acidic string of amino acids but not tyrosine 315 (amino acids 304 through 310 are deleted), whereas the middle T antigen encoded by the other mutant, pPdl2-7, lacks the entire acidic amino acid stretch as well as tyrosine 315 (amino acids 285 through 323 are deleted). Rat-1 cells transformed by one or the other mutant DNA displayed a fully transformed phenotype, including the capacity to form tumors in animals. These results prove that the major site of tyrosine phosphorylation in middle T antigen and the acidic amino acids which precede it are not essential for its transforming activity.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6092671      PMCID: PMC254546     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

1.  New classes of viable deletion mutants in the early region of polyoma virus.

Authors:  B E Griffin; C Maddock
Journal:  J Virol       Date:  1979-09       Impact factor: 5.103

2.  Polyoma virus-specific 55K protein isolated from plasma membrane of productively infected cells is virus-coded and important for cell transformation.

Authors:  Y Ito
Journal:  Virology       Date:  1979-10-15       Impact factor: 3.616

3.  Sequence from early region of polyoma virus DNA containing viral replication origin and encoding small, middle and (part of) large T antigens.

Authors:  E Soeda; J R Arrand; N Smolar; B E Griffin
Journal:  Cell       Date:  1979-06       Impact factor: 41.582

4.  Protein kinase activity associated with polyoma virus middle T antigen in vitro.

Authors:  A E Smith; R Smith; B Griffin; M Fried
Journal:  Cell       Date:  1979-12       Impact factor: 41.582

5.  Translation of polyoma virus T antigens in vitro.

Authors:  T Hunter; M A Hutchinson; W Eckhart
Journal:  Proc Natl Acad Sci U S A       Date:  1978-12       Impact factor: 11.205

6.  Tumor antigen(s) in cell productively infected by wild-type polyoma virus and mutant NG-18.

Authors:  B S Schaffhausen; J E Silver; T L Benjamin
Journal:  Proc Natl Acad Sci U S A       Date:  1978-01       Impact factor: 11.205

7.  Tumor antigens induced by nontransforming mutants of polyoma virus.

Authors:  J Silver; B Schaffhausen; T Benjamin
Journal:  Cell       Date:  1978-10       Impact factor: 41.582

8.  Biochemical transfer of single-copy eucaryotic genes using total cellular DNA as donor.

Authors:  M Wigler; A Pellicer; S Silverstein; R Axel
Journal:  Cell       Date:  1978-07       Impact factor: 41.582

9.  A new method for sequencing DNA.

Authors:  A M Maxam; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

10.  Virus-specific proteins in the plasma membrane of cells lytically infected or transformed by pol-oma virus.

Authors:  Y Ito; J R Brocklehurst; R Dulbecco
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

View more
  7 in total

1.  The amino terminus of polyomavirus middle T antigen is required for transformation.

Authors:  D N Cook; J A Hassell
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

2.  Significance of the gastrin homology and surrounding sequences in polyomavirus middle T antigen for cell transformation.

Authors:  K L Clark; W R Folk
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

3.  Site-directed mutagenesis of polyomavirus middle-T antigen sequences encoding tyrosine 315 and tyrosine 250.

Authors:  W Markland; B A Oostra; R Harvey; A F Markham; W H Colledge; A E Smith
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

4.  Overproduction of polyomavirus middle T antigen in mammalian cells through the use of an adenovirus vector.

Authors:  D Davidson; J A Hassell
Journal:  J Virol       Date:  1987-04       Impact factor: 5.103

5.  Association of p62c-yes with polyomavirus middle T-antigen mutants correlates with transforming ability.

Authors:  S Kornbluth; S H Cheng; W Markland; Y Fukui; H Hanafusa
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

6.  Genetic mapping of a major site of phosphorylation in adenovirus type 2 E1A proteins.

Authors:  A S Tsukamoto; A Ponticelli; A J Berk; R B Gaynor
Journal:  J Virol       Date:  1986-07       Impact factor: 5.103

7.  A new member of the polyomavirus family: the hamster papovavirus. Complete nucleotide sequence and transformation properties.

Authors:  V Delmas; C Bastien; S Scherneck; J Feunteun
Journal:  EMBO J       Date:  1985-05       Impact factor: 11.598

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.